Skip to main content
    C

    CME Group Inc (CME)

    Official site

    FINANCIAL SERVICES • FINANCIAL DATA & STOCK EXCHANGES • NASDAQ

    $319.37
    +1.40 (+0.44%)

    Market Cap: $113.81B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    CME Group Inc (CME) Earnings: Report Dates and Results

    Updated Oct 21, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    CME Group (CME) is expected to report earnings on Feb 2, 2027. In the quarter ended Sep 30, 2026, CME Group reported EPS of $3.02, above the $2.98 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    85%(34/40)
    Avg Surprise
    +1.88%
    Streak
    2 Q

    Upcoming Estimates

    Reports Feb 2, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$3.06
    Range$2.86 - $3.44
    16 analysts
    Revenue Consensus
    $1.79B
    Range$1.69B - $1.97B
    15 analysts
    Reports Apr 20, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$3.32
    Range$3.05 - $3.60
    12 analysts
    EPS Revisions
    7
    4
    30d
    EPS Estimate DriftChange to current
    90d ago$3.29+1.1%
    60d ago$3.29+1.1%
    30d ago$3.28+1.2%
    7d ago$3.30+0.5%
    Current$3.32
    Revenue Consensus
    $1.86B
    Range$1.73B - $1.97B
    8 analysts

    Next Report

    CME has an expected report date of Feb 2, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 10.5% above the $2.77 reported for the quarter ended Dec 31, 2025.

    CME Earnings Call

    The latest CME earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, CME beat 34, missed 5 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $1.74B, up 13.0% from $1.54B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$3.02$2.98$2.90 - $3.07+1.34%Beat+12.7%147 up, 2 downOct 21, 2026$1.74B
    Jun 30, 2026$2.99$2.91$2.84 - $2.94+2.75%Beat+1.0%122 up, 1 downJul 22, 2026$1.71B
    Mar 31, 2026$3.36$3.37$3.29 - $3.48-0.30%Miss+20.0%1311 up, 1 downApr 22, 2026$1.88B
    Dec 31, 2025$2.77$2.74$2.70 - $2.78+1.09%Beat+9.9%126 up, 6 downFeb 4, 2026$1.65B
    Sep 30, 2025$2.68$2.63$2.56 - $2.67+1.90%Beat0.0%144 up, 10 downOct 22, 2025$1.54B
    Jun 30, 2025$2.96$2.92$2.85 - $3.00+1.37%Beat+15.6%153 up, 9 downJul 23, 2025$1.69B
    Mar 31, 2025$2.80$2.81$2.78 - $2.86-0.36%Miss+12.0%1512 up, 1 downApr 23, 2025$1.64B
    Dec 31, 2024$2.52$2.45$2.40 - $2.48+3.05%Beat+6.3%154 up, 10 downFeb 12, 2025$1.53B
    Sep 30, 2024$2.68$2.65$2.61 - $2.73+1.13%Beat+19.1%1511 up, 1 downOct 23, 2024$1.58B
    Jun 30, 2024$2.56$2.53$2.50 - $2.57+1.19%Beat+11.3%136 up, 1 downJul 24, 2024$1.53B
    Mar 31, 2024$2.50$2.45$2.39 - $2.50+2.04%Beat+3.3%145 up, 1 downApr 24, 2024$1.49B
    Dec 31, 2023$2.37$2.28$2.23 - $2.33+3.95%Beat+23.4%142 up, 0 downFeb 14, 2024$1.44B
    Sep 30, 2023$2.25$2.22$2.18 - $2.27+1.35%Beat+13.6%149 up, 0 downOct 25, 2023$1.34B
    Jun 30, 2023$2.30$2.19$2.15 - $2.25+5.02%Beat+16.8%1513 up, 0 downJul 26, 2023$1.36B
    Mar 31, 2023$2.42$2.38$2.29 - $2.47+1.68%Beat+14.7%1412 up, 0 downApr 26, 2023$1.44B
    Dec 31, 2022$1.92$1.88$1.82 - $1.94+2.13%Beat+15.7%152 up, 0 downFeb 8, 2023$1.21B
    Sep 30, 2022$1.98$1.94$1.89 - $1.99+2.06%Beat+23.7%159 up, 0 downOct 26, 2022$1.23B
    Jun 30, 2022$1.97$1.93$1.89 - $1.98+2.07%Beat+20.1%1310 up, 0 downJul 27, 2022$1.24B
    Mar 31, 2022$2.11$2.00$1.93 - $2.08+5.50%Beat+17.9%1610 up, 0 downApr 27, 2022$1.35B
    Dec 31, 2021$1.66$1.64$1.59 - $1.70+1.22%Beat+19.4%15N/AFeb 9, 2022$1.15B
    Sep 30, 2021$1.60$1.55$1.52 - $1.64+3.23%Beat+15.9%14N/AOct 27, 2021$1.11B
    Jun 30, 2021$1.64$1.61$1.56 - $1.72+1.86%Beat+0.6%17N/AJul 28, 2021$1.18B
    Mar 31, 2021$1.79$1.76$1.54 - $1.80+1.70%Beat-23.2%18N/AApr 28, 2021$1.25B
    Dec 31, 2020$1.39$1.36$1.32 - $1.52+2.21%Beat-8.6%18N/AFeb 10, 2021$1.10B
    Sep 30, 2020$1.38$1.44$1.32 - $1.48-4.17%Miss-27.4%18N/AOct 28, 2020$1.08B
    Jun 30, 2020$1.63$1.64$1.56 - $1.66-0.61%Miss-7.4%17N/AJul 29, 2020$1.18B
    Mar 31, 2020$2.33$2.21$2.20 - $2.28+5.43%Beat+43.8%17N/AApr 29, 2020$1.52B
    Dec 31, 2019$1.52$1.55$1.51 - $1.62-1.94%Miss-14.1%17N/AFeb 12, 2020$1.14B
    Sep 30, 2019$1.90$1.75$1.67 - $1.79+8.57%Beat+31.0%16N/AOct 30, 2019$1.28B
    Jun 30, 2019$1.76$1.76$1.72 - $1.790.00%In line+1.1%15N/AJul 31, 2019$1.27B
    Mar 31, 2019$1.62$1.60$1.52 - $1.67+1.25%Beat-12.9%15N/AMay 1, 2019$1.18B
    Dec 31, 2018$1.77$1.72$1.46 - $1.77+2.91%Beat+58.0%16N/AFeb 14, 2019$1.24B
    Sep 30, 2018$1.45$1.43$1.41 - $1.44+1.40%Beat+21.8%10N/AOct 25, 2018$904.20M
    Jun 30, 2018$1.74$1.72$1.69 - $1.75+1.16%Beat+41.5%9N/AJul 26, 2018$1.06B
    Mar 31, 2018$1.86$1.85$1.59 - $1.87+0.54%Beat+52.5%10N/AApr 26, 2018$1.11B
    Dec 31, 2017$1.12$1.10$1.07 - $1.11+1.82%Beat-1.8%13N/AFeb 1, 2018$900.00M
    Sep 30, 2017$1.19$1.16$1.13 - $1.17+2.59%Beat+13.3%14N/AOct 26, 2017$890.80M
    Jun 30, 2017$1.23$1.21$1.20 - $1.21+1.65%Beat+12.8%12N/AAug 1, 2017$924.60M
    Mar 31, 2017$1.22$1.20N/A+1.67%Beat+6.1%N/AN/AApr 27, 2017$929.30M
    Dec 31, 2016$1.14$1.10N/A+3.64%Beat+23.9%N/AN/AFeb 2, 2017$912.90M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $11.21, up 9.3% from the year before. It was $4.43 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$11.21+9.3%
    Dec 31, 2024$10.26+9.9%
    Dec 31, 2023$9.34+17.0%
    Dec 31, 2022$7.98+19.3%
    Dec 31, 2021$6.69N/A
    Dec 31, 2020$6.73-1.0%
    Dec 31, 2019$6.80N/A
    Dec 31, 2018$6.82+43.3%
    Dec 31, 2017$4.76+7.4%
    Dec 31, 2016$4.43N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,300 words across 22 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20269,34722
    2026Q2Jun 30, 20269,97921
    2026Q1Mar 31, 202610,65921
    2025Q4Dec 31, 20256,96117
    2025Q3Sep 30, 20258,24322
    2025Q2Jun 30, 20257,73624
    2025Q1Mar 31, 20259,84823
    2024Q4Dec 31, 20249,04120

    2026Q3 Earnings Call

    Opening remarks

    Adam Minick Vice President, Investor Relations Good morning, and I hope you're all doing well today. Earlier this morning, we released our earnings commentary, which provides extensive details on the third quarter 2026, which we will be discussing on this call. I'll start with the safe harbor language, and then I'll turn it over to Terry. Statements made on this call and in the other reference documents on our websites that are not historical facts are forward-looking statements. These statements are not guarantees of future performance. They involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any statement. Detailed information about factors that may affect our performance can be found in the filings with the SEC, which are on our website. Lastly, in the earnings release, you will see a reconciliation between GAAP and non-GAAP measures following the financial statements. With that, I'll turn the call over to our Chairman and CEO, Terry Duffy.

    Terry Duffy Chairman and CEO Thanks, Adam, and thank you all for joining us this morning. I'll make a few comments about our exceptional third quarter performance before turning it over to Lynne to provide an overview of our financial results. In addition to Lynne, we have other members of our management team present to answer questions after the prepared remarks. Against a backdrop of shifting central bank policies, geopolitical uncertainty, and persistent market volatility, global participants continue to turn to CME Group in record numbers. The third quarter average daily volume of 29.4 million contracts was the highest third-quarter average daily volume in CME Group's history and increased 16% compared to the same period last year. This strong growth was broad-based as we achieved double-digit year-over-year volume growth in all six asset classes. Our financial and commodity products volume each grew by 16%. Beyond the strong volume growth, the underlying health of the business is perhaps best reflected in the strength of our open interest and the significant capital efficiencies we provide to our customers. Quarter-end open interest reached 128 million contracts, and today it is over 133 million, the highest open interest at the end of September in our history. As I said, this open interest continues to grow in October. We also set a record for the number of large open interest holders in both our interest rates and foreign exchange complexes in September. Additionally, we delivered record levels of capital efficiency in the third quarter, saving our customers an average of over $100 billion a day in margin savings. This was a record third quarter for our international business as well, where average daily volume reached 9 million contracts, up 22% versus last year.

    Frequently Asked Questions About CME

    When is CME Group's next earnings date?

    CME Group's next earnings report is expected for Feb 2, 2027.

    Did CME beat earnings estimates last quarter?

    Yes. CME Group reported EPS of $3.02 for the quarter ended Sep 30, 2026, above the $2.98 estimate, a 1.34% surprise.

    What EPS do analysts expect from CME next quarter?

    The consensus EPS estimate for CME Group for the quarter ending Dec 31, 2026 is $3.06 from 16 analysts, with estimates from $2.86 to $3.44.

    How often does CME beat earnings estimates?

    CME Group beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +1.36%.